FDA Label for Esokalli Slimming Microcrystalline Patch
View Indications, Usage & Precautions
Esokalli Slimming Microcrystalline Patch Product Label
The following document was submitted to the FDA by the labeler of this product Guangzhou Yixin Cross-border E-commerce Co., Ltd.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Active Ingredient (In Each Patch)
Retatrutide 1.6 mg ……………………………. Weight management / blood sugar control
Purpose
Weight loss aid
Improves blood sugar control (when used with diet and exercise)
Uses
To support weight management
To improve glycemic control in adults with type 2 diabetes mellitus
Provides long-acting sustained-release delivery via soluble microneedle patch
Warnings
For external use only
Dosage And Administration
For external use only.
Do Not Use If You
have type 1 diabetes
need treatment for diabetic ketoacidosis
are pregnant or breastfeeding
are under 18 years of age
When Using This Product
monitor blood glucose regularly
possible side effects include:
hypoglycemia
nausea, vomiting, or diarrhea
acute pancreatitis
complications of diabetic retinopathy
increased heart rate
hypersensitivity or allergic reactions
Stop Use And Ask A Doctor If
• you develop severe abdominal pain (possible acute pancreatitis)
• symptoms of hypersensitivity occur (rash, swelling, difficulty breathing)
• persistent gastrointestinal problems occur
Keep Out Of Reach Of Children.
In case of accidental ingestion, get medical help or contact a Poison Control Center right away.
Inactive Ingredients
Microcrystalline matrix, soluble microneedle polymer blend, stabilizers, adhesive layer.
Principal Display Panel
* Please review the disclaimer below.
